chartexchange

UTHR
United Therapeutics Corp
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
577.56USD-1.120%(-6.54)416,610
After-hoursNov 18, 2026 4:40:30 PM EST
577.34USD-0.038%(-0.22)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Martine Rothblatt
HQ
Silver Spring, MD, USA
Previous Close
$584.10
Beta
0.43
52-Week High
$614.23 2026-11-04
52-Week Low
$455.63 2026-01-20
SMA 50
$546.33
SMA 200
$538.59
Avg. Vol 10D
510,562
Avg. Vol 30D
596,874
Avg. Vol 90D
643,466
Relative Vol
0.73
38.91M
0.2500%
Sep 23, 2009 · 2-for-1
UTHR Profile

united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of "medicines for life" and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians

UTHR Performance
PeriodPriceDateChangeBeta
1W595.662026-11-11-3.04%0.127
1M543.152026-10-19+6.33%1.032
3M518.272026-08-18+11.44%0.701
6M566.992026-05-18+1.86%0.283
1Y476.592025-11-18+21.18%0.432
2Y359.212024-11-18+60.78%—
5Y202.612021-11-18+185.06%0.406
UTHR Stock Summary

United Therapeutics Corp (NASDAQ:UTHR) stock price today is $577.55, and today's volume is 433,871. UTHR is down 1.121% today. The 30 day average volume is 596,874. UTHR market cap is $24.60B with 42.59M shares outstanding.